arrow
M

María Gutiérrez-Fernández

Hospital La Paz Institute for Health Research and Universidad Autónoma de Madrid
H指数:28
被引数:2,791

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extracellular Vesicles from Poor-Outcome Intracerebral Hemorrhage Patients Reveal Limited Reparative Potential in a Preclinical Model

来自预后不良的颅内出血患者的细胞外囊泡在预临床模型中显示出有限的修复潜力

2026-03-030
OAAI
Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes
2025-11-010
PRE
Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis

基于免疫检查点的生物标志物用于多发性硬化患者的治疗反应

2025-10-200
OAAI
The proteomic signature of circulating extracellular vesicles following intracerebral hemorrhage: Novel insights into mechanisms underlying recovery
2024-10-011
OAAI
The impact of experimental diabetes on intracerebral haemorrhage. A preclinical study

实验性糖尿病对脑出血的影响。临床前研究

2024-07-012
OAAI
The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis
2023-11-0112
OAAI
Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis

脑和免疫系统来源的细胞外囊泡介导多发性硬化的补体系统调节,细胞外基质重塑,脑修复和抗原耐受

2023-10-0110
OAAI
Dual role of peripheral B cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers
2023-08-103
OAAI
Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage
2023-06-016
OAAI
Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage
2023-01-198
OAAI
Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial
2022-03-1838
OAAI
Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study
2020-11-049
OAAI